Literature DB >> 11237316

Depressive syndromes in dementia.

L Thorpe1, B Groulx.   

Abstract

BACKGROUND: Depressive syndromes in dementia are common, treatment is challenging and controlled intervention studies are small in number. The goal of this paper is to review known information about the etiology, epidemiology and treatment of these syndromes, as summarized at the recent Canadian Consensus Conference on Dementia.
METHODS: A number of Medline searches were performed (most recently updated in October 2000) using the subject categories dementia and depression, or apathy or emotional lability and other relevant articles were also reviewed. The background article was edited and amended at the Consensus Conference on Dementia. Final recommendations appearing in the summary article by Patterson et al were accepted by the group consensus process. Clinical discussion and informational updates were added for the current text by the authors.
RESULTS: Depressive syndromes, ranging in severity from isolated symptoms to full depressive disorders, increase in dementia. While clear-cut depressive disorder is increased in this population, sub-syndromal disorders are even more common and cause considerable distress. Antidepressant treatment may improve the quality of life in depressed, demented people, although it is less successful than in those without cognitive impairment and carries more risk of iatrogenic effects.
CONCLUSIONS: Physicians should be alert to the presence of depressive syndromes in dementia. Depressive illness should be treated and, when necessary, referral should be made to an appropriate specialist. Treatment must minimize iatrogenic effects. Although there is some support for treatment of syndromes that do not meet criteria for depressive disorder or dysthymia, the first line of intervention in these situations should involve nonpharmacological approaches.

Entities:  

Mesh:

Year:  2001        PMID: 11237316     DOI: 10.1017/s0317167100001256

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  5 in total

Review 1.  Can Animal Models Inform on the Relationship between Depression and Alzheimer Disease?

Authors:  Jennifer N K Nyarko; Maa O Quartey; Glen B Baker; Darrell D Mousseau
Journal:  Can J Psychiatry       Date:  2018-04-23       Impact factor: 4.356

2.  Alzheimer disease-related presenilin-1 variants exert distinct effects on monoamine oxidase-A activity in vitro.

Authors:  Paul R Pennington; Zelan Wei; Lewei Rui; Jennifer A Doig; Brett Graham; Kelly Kuski; Geraldine G Gabriel; Darrell D Mousseau
Journal:  J Neural Transm (Vienna)       Date:  2011-03-04       Impact factor: 3.575

3.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

4.  Saccadic eye movements in depressed elderly patients.

Authors:  Nicolas Carvalho; Nicolas Noiret; Pierre Vandel; Julie Monnin; Gilles Chopard; Eric Laurent
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

5.  Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures: implications for Alzheimer disease-related pathology.

Authors:  Xia Cao; Zelan Wei; Geraldine G Gabriel; XinMin Li; Darrell D Mousseau
Journal:  BMC Neurosci       Date:  2007-09-16       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.